Ophthalmology Drugs Market Analysis 2023-2032: Size, Outlook, Growth, Segments And Trends | Regeneron Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Novartis AG, Bayer AG, AbbVie Inc

As per The Business Research Company's Ophthalmology Drugs Opportunities And Strategies Market Report 2023, The global ophthalmology drugs market size reached a value of nearly $50,563.47 million in 2021, having increased at a compound annual growth rate (CAGR) of 5.99% since 2016. The market is expected to grow from $50,563.47 million in 2021 to $77,524.68 million in 2026 at a rate of 8.92%. The global ophthalmology drugs market size is then expected to grow at a CAGR of 7.65% from 2026 and reach $112,076.64 million in 2031.  

Changes of working lifestyles towards digitalization of the workspace and rise in sedentary jobs are forcing people to spend long hours in front of a computer screen, driving the demand for dry eye medication. Increasing cases of dry eyes from excessive time spent on electronic devices such as phones and computers has led to the development of the term "digital eye strain" or "computer vision syndrome." It is increasingly becoming a widespread problem as more and more people are spending hours staring at computers, cellphones, and other electronic devices. In a survey published in 2021, around 227 students were surveyed. Of these respondents, 90.3% (205 students) reported experiencing the ocular and extra-ocular symptoms of digital eye strain (DES).  The continuous digitalization of the workplace is expected to be a major driver for the dry eye medications contributing to the growth of the ophthalmology drugs market.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Companies in the dry eye medication market are increasing their investments in the developing regions of South America, Africa, and Asia to capitalize on untapped market opportunities. For example, in August 2022, Alcon, an American Swiss medical company specializing in eye care products acquired Aerie Pharmaceuticals, Inc. for an undisclosed amount This transaction confirms Alcon's commitment to the ophthalmic pharmaceutical industry and is anticipated to boost the value of its diversified portfolio by boosting Alcon's current commercial expertise with broader pharmaceutical R&D capabilities. Aerie Pharmaceuticals Inc. is an USA based publicly traded, clinical-stage pharmaceutical company founded in 2005.

The top opportunities in the ophthalmology drugs market by type will arise in the other ophthalmological drugs market, which will gain $16,427.7 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by distribution channel will arise in the retail pharmacies/ drug stores market, which will gain $12,002.1 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by mode of purchase will arise in the prescription-based drugs market, which will gain $15,620.2 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by route of administration will arise in the topical market, which will gain $16,639.5 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by drug classification will arise in the generic drugs market, which will gain $14,873.5 million of global annual sales by 2026. The ophthalmology drugs market size will gain the most in the USA at $8,734.8 million.

Ophthalmology Drugs Market Segmentation:

The Ophthalmology Drugs market is segmented by type, by distribution channel, by route of administration, by drug classification, and by delivery model.

By Type -
The ophthalmology drugs market is segmented by type into
a) Antiglaucoma Drugs
b) Dry Eye Medication
c) Other Ophthalmological Drugs

By Distribution Channel -
The ophthalmology drugs market is segmented by distribution channel into
a) Hospital Pharmacies
b) Retail Pharmacies/ Drug Stores
c) Other Distribution Channels

By Route Of Administration -
The ophthalmology drugs market is segmented by route of administration into
a) Topical
b) Oral
c) Other Route Of Administration

By Drug Classification -
The ophthalmology drugs market is segmented by drug classification into
a) Branded Drugs
b) Generic Drugs

By Mode Of Purchase -
The ophthalmology drugs market is segmented by mode of purchase into
a) Over-The-Counter Drugs
b) Prescription-Based Drugs

Major players in the Ophthalmology Drugs market include Regeneron Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Novartis AG, Bayer AG, AbbVie Inc.

The regions covered in the global Ophthalmology Drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=2142&type=smp

The latest report from The Business Research Company, 'Global Ophthalmology Drugs Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Ophthalmology Drugs Market Report Table Of Content

1. Ophthalmology Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction to the Ophthalmology Drugs market
……
25. Key Mergers And Acquisitions In The Ophthalmology Drugs Market
26. Market Background: Nursing Care
27. Ophthalmology Drugs Market Opportunities And Strategies
28. Ophthalmology Drugs Market, Conclusions And Recommendations
29. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2142

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.